EGFR and non-small cell lung carcinoma: More recently, the SBRT in newly diagnosed advanced staged lung adenocarcinoma (SINDAS) trial was the first published phase III trial evaluating the role of TKI with or without radiotherapy in patients with EGFR driven oligometastatic NSCLC [34].